Status:
COMPLETED
Levosimendan Administration and Outcome in Cardiac Surgery
Lead Sponsor:
Charite University, Berlin, Germany
Conditions:
Treatment of Left Heart Insufficiency in an Operative Setting of Cardiac Surgery
Eligibility:
All Genders
18+ years
Brief Summary
To assess the effects on outcome of levosimendan with respect to timing of its administration on the postoperative course of high-risk cardiac surgery patients in a retrospective observational study.
Eligibility Criteria
Inclusion
- patients undergoing cardiac surgery between 2006 and 2013
- levosimendan administration within 24 hours of postoperative ICU admission
Exclusion
- patients younger than 18
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
159 Patients enrolled
Trial Details
Trial ID
NCT02275013
Start Date
January 1 2006
End Date
December 1 2013
Last Update
October 27 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Charité University Medicine
Berlin, State of Berlin, Germany, 10117